Table 3.
N | Ballooning grade | Fibrosis stage | |||||
---|---|---|---|---|---|---|---|
G0 | G1–2 | P-value | S0–2 | S3–4 | P-value | ||
SHH+ bile ducts/ductules | 15 | 2[1, 2] | 1[0, 2] | NS | 2[0.5, 2] | 1.5[1, 2] | NS |
% PTs with SHH+ periportal hepatocytes | 16 | 53%[3%, 97%] | 0%[0%, 19%] | 0.061 | 12.5%[0%, 55%] | 89%[13%, 100%] | 0.086 |
Intensity of SHH+ staining in periportal hepatocytes | 16 | 1.5[0.3, 2] | 0[0, 0.8] | 0.061 | 0.5[0, 1.8] | 2[1, 2] | NS |
K7 proliferation score | 25 | 2[1, 3] | 2.5[1.3, 3] | NS | 1[1, 2.5] | 2[2, 3] | NS |
GLI2 activity in PT cells | 18 | 2[1, 3] | 2[2, 3] | NS | 2[1, 2.3] | 2[1.8, 3] | NS |
SHH+ ballooned hepatocytes | 15 | 0[0, 0.08] | 4[2.8, 7.8] | 0.003 | 2.5[0, 4.5] | 0[0, 0.5] | 0.063 |
No associations were noted with steatosis, portal inflammation, and lobular inflammation. NS (not significant): p>0.1
G, grade; S, stage; PT, portal tract